Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
KYNB — Kyntra Bio, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 11, 2026
REVENUE
$3.7M +192.7%
NET MARGIN
-406.6% -3377.8 PTS
EPS
-$3.76 -140.1%
FREE CASH FLOW
-$13.9M +24.2%

No summary has been written for this call yet.